These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9460553)

  • 21. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
    Waibel R; Alberto R; Willuda J; Finnern R; Schibli R; Stichelberger A; Egli A; Abram U; Mach JP; Plückthun A; Schubiger PA
    Nat Biotechnol; 1999 Sep; 17(9):897-901. PubMed ID: 10471933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
    Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
    Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiments on a new phosphine-peptide chelator for labelling of peptides with Tc-99m.
    Santimaria M; Blok D; Feitsma RI; Mazzi U; Pauwels EK
    Nucl Med Biol; 1999 Apr; 26(3):251-8. PubMed ID: 10363795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method.
    Pak KY; Nedelman MA; Tam SH; Wilson E; Daddona PE
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):669-77. PubMed ID: 1522021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
    Decristoforo C; Mather SJ
    Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
    Griffiths GL; Goldenberg DM; Roesch F; Hansen HJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3001s-3003s. PubMed ID: 10541334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties.
    Maes V; Garcia-Garayoa E; Bläuenstein P; Tourwé D
    J Med Chem; 2006 Mar; 49(5):1833-6. PubMed ID: 16509599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibody radiolabeling with technetium-99m].
    Perera A; Pérez C
    Rev Esp Med Nucl; 1998; 17(4):302-9. PubMed ID: 9721347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast and specific labeling of antibody fragments with multiple atoms of heavy metal radioisotopes.
    Trubetskoy VS; Torchilin VP
    Anal Biochem; 1995 Aug; 229(2):345-7. PubMed ID: 7485993
    [No Abstract]   [Full Text] [Related]  

  • 32. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
    Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new method of technetium-99m labeling of monoclonal antibodies through sugar residues. A study with TAG-72 specific CC-49 antibody.
    Ranadive GN; Rosenzweig HS; Epperly MW; Seskey T; Bloomer WD
    Nucl Med Biol; 1993 Aug; 20(6):719-26. PubMed ID: 8401372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with 99mTc-tricarbonyl.
    D'Andrea LD; Testa I; Panico M; Di Stasi R; Caracò C; Tarallo L; Arra C; Barbieri A; Romanelli A; Aloj L
    Biopolymers; 2008; 90(5):707-12. PubMed ID: 18615495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m.
    Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
    Cancer Res; 1980 Aug; 40(8 Pt 2):3043-5. PubMed ID: 7397698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes.
    Cooper MS; Sabbah E; Mather SJ
    Nat Protoc; 2006; 1(1):314-7. PubMed ID: 17406251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
    Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
    J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator.
    Tibben JG; Massuger LF; Boerman OC; Claessens RA; Borm GF; Pak KY; Koenders EB; Corstens FH
    Nucl Med Biol; 1994 Jan; 21(1):17-24. PubMed ID: 9234260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases.
    Chianelli M; Signore A; Fritzberg AR; Mather SJ
    Nucl Med Biol; 1997 Aug; 24(6):579-86. PubMed ID: 9316088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.